ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00047606
Recruitment Status : Terminated (Management Decision)
First Posted : October 11, 2002
Last Update Posted : August 17, 2012
Sponsor:
Information provided by (Responsible Party):
Alcon Research

Brief Summary:
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.

Condition or disease Intervention/treatment Phase
Open-angle Glaucoma Ocular Hypertension Drug: IOP Lowering Medications Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 84 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32.
Study Start Date : August 2002
Actual Primary Completion Date : November 2003
Actual Study Completion Date : November 2003

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
Adults of Caucasian and Japanese Ethnicity

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00047606     History of Changes
Other Study ID Numbers: C-02-32
First Posted: October 11, 2002    Key Record Dates
Last Update Posted: August 17, 2012
Last Verified: August 2008

Keywords provided by Alcon Research:
open-angle
glaucoma
ocular
hypertension
POAG
Iris
Pigmentation
Japanese

Additional relevant MeSH terms:
Hypertension
Glaucoma
Glaucoma, Open-Angle
Ocular Hypertension
Vascular Diseases
Cardiovascular Diseases
Eye Diseases